FMR CORP 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 17,731,269 16.252% |
4,683,939 (+35.90%) |
Filing |
| 2023-07-10 10:20 am Purchase |
2023-07-07 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 13,047,330 12.658% |
4,154,232 (+46.71%) |
Filing |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 8,893,098 8.780% |
-4,385,709 (-33.03%) |
Filing |
| 2022-02-09 09:07 am Sale |
2022-02-08 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 13,278,807 13.594% |
-467,707 (-3.40%) |
Filing |
| 2021-12-10 08:52 am Sale |
2021-12-09 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 13,746,514 14.059% |
-2,915,302 (-17.50%) |
Filing |
| 2021-02-08 10:13 am Purchase |
2021-02-05 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 16,661,816 19.207% |
4,520,624 (+37.23%) |
Filing |
| 2020-05-11 08:45 am Purchase |
2020-05-08 | 13G | 10x Genomics, Inc. TXG |
FMR CORP | 12,141,192 18.710% |
421,603 (+3.60%) |
Filing |